Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00345-009-0402-4.pdf
Reference21 articles.
1. Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S (2007) The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. BJU Int 100:33–36. doi: 10.1111/j.1464-410X.2007.06912.x
2. Malavaud B (2004) T1 G3 bladder tumours: the case for radical cystectomy. Eur Urol 45:406–410. doi: 10.1016/j.eururo.2003.11.007
3. Evans CP, Busby JE (2003) The management of stage T1 grade 3 transitional cell carcinoma of the bladder. BJU Int 92:345–348. doi: 10.1046/j.1464-410X.2003.04357.x
4. Stein JP, Penson DF (2008) Invasive T1 bladder cancer: indications and rationale for radical cystectomy. BJU Int 102:270–275. doi: 10.1111/j.1464-410X.2008.07743.x
5. Denzinger S, Fritsche HM, Otto W, Blana A, Wieland WF, Burger M (2008) Early versus deferred cystectomy for initial high-risk pT1 G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? Eur Urol 53:146–152. doi: 10.1016/j.eururo.2007.06.030
Cited by 83 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identifying novel biomarkers associated with bladder cancer treatment outcomes;Frontiers in Oncology;2023-03-29
2. A longitudinal single center analysis of T1HG bladder cancer: An 18 year experience;Urologic Oncology: Seminars and Original Investigations;2022-11
3. The delay in the diagnosis and treatment of newly diagnosed bladder cancer patients during COVID 19 pandemic;African Health Sciences;2022-10-27
4. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer;Cancers;2022-08-04
5. Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study;European Urology Open Science;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3